Human cloning advocates and their media allies are steeped in regret over the “years” that Hwang has allegedly cost cloning science. This piece in the Observer is well written and a prime example of this line of thinking. (And the description of therapeutic cloning is pretty accurate!)
Lost in all of this mourning are the tremendous advances being made in the very areas to which therapeutic cloning would supposedly bring relief. From the column: “The ravaged brains of Alzheimer’s victims would one day be provided with new nerve cells; diabetics would be given pancreatic cells to replace those killed off by their condition; and victims of cardiac disease would be treated with fresh heart muscle cells.The promise was immense.”
The “promise” is and was purely theoretical and speculative. Alzheimer’s, as has been repeatedly noted here, is NOT a good candidate for treatment with embryonic stem cells. As for diabetes, mice with late stage disease have been cured with adult spleen stem cells. Nothing close to that with cloned or natural embryonic stem cells. Yet, even though the FDA has approved human trials, the Harvard scientists who want to see if it will work in humans are having trouble obtaining financing. (The Juvenile Diabetes Research Foundation refuses to fund the study, but put over $1 million into Proposition 71.) Heart disease is also already being treated in early trials with adult stem cells. The list goes on and on.
No mention in the article of these avenues of great hope. Also, no mention of the bigger picture issues about what such a massive fraud means about peer review, the unskeptical media, and whether the “promise” of embryonic approaches are really as bright as has been stated.
I am convinced that media and cloning advocates will refuse to learn the deeper lessons of this scandal. It will be up to alternative media to keep that aspect of the story alive.
Dear Reader,
Can I be direct with you?
War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.
First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.
But we can’t do it without readers like you.
Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.
Your gift anchors readers in the permanent things.
Make your Fall Campaign gift now using the button below.
If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.
YOU MIGHT ALSO LIKE
The Church in the Age of Therapy
In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…
Canada’s Deadliest Blind Spot
On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…
The Faithful Joy of Dolly Parton and Fulton Sheen
Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…
